Skip to main content

Table 4 Surgical interventions and morbidity

From: Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution

  IPMN (n = 17) MCN (n = 20) SCN (n = 39) SPN (n = 35)
Types of resection, n (%)     
Distal pancreatectomy, splenectomy 2 (11.8%) 11 (55%) 11 (28.2%) 12 (34.3%)
Spleen-preserving distal pancreatectomy 2 (11.8%) 6 (30%) 3 (7.7%) 3 (8.6%)
Pancreaticoduodenectomy 11 (64.7%)   6 (15.4%) 9 (25.7%)
Pylorus-preserving pancreaticoduodenectomy    1 (2.6%)  
Middle pancreatectomy    12 (30.8%) 5 (14.3%)
Tumor enucleation 1 (5.9%) 2 (10%) 6 (15.4%) 6 (17.1%)
Laparotomy with biopsy   1 (5%)   
Total pancreatectomy 1 (5.9%)    
Postoperative complications, n (%) 8 (47.1%) 6 (30%) 15 (38.5%) 21 (60%)
No complications, n (%) 9 (52.9%) 14 (70%) 24 (61.5%) 14 (40%)
Re-operation (n) 0 0 2 (5.1%) 2 (5.7%)
Hospital stay after surgery, days, median (range) 19.0 (12.0-74.0) 13.0 (8.0-26.0) 20.0 (7.0-123.0) 16.0 (7.0-99.0)